Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.

Newton NM, Agrawal K, Odell AV, Tracy T, Hackett C, Eldrup A, Whitfield M, Martyanov V, Girardi M, Sefik E, Flavell RA, Odell ID.

Open source

DOI: 10.1182/blood.2025029836
Published: 2025-12-01
Container: Blood
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025029836,
  title = {Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.},
  author = {Newton NM and  Agrawal K and  Odell AV and  Tracy T and  Hackett C and  Eldrup A and  Whitfield M and  Martyanov V and  Girardi M and  Sefik E and  Flavell RA and  Odell ID.},
  year = {2025},
  journal = {Blood},
  doi = {10.1182/blood.2025029836},
  url = {https://doi.org/10.1182/blood.2025029836}
}

RIS

TY  - JOUR
TI  - Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.
AU  - Newton NM
AU  -  Agrawal K
AU  -  Odell AV
AU  -  Tracy T
AU  -  Hackett C
AU  -  Eldrup A
AU  -  Whitfield M
AU  -  Martyanov V
AU  -  Girardi M
AU  -  Sefik E
AU  -  Flavell RA
AU  -  Odell ID.
PY  - 2025
JO  - Blood
DO  - 10.1182/blood.2025029836
UR  - https://doi.org/10.1182/blood.2025029836
ER  -

APA

NM, N., K, A., AV, O., T, T., C, H., A, E., M, W., V, M., M, G., E, S., RA, F., & ID., O. (2025). Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.. Blood. https://doi.org/10.1182/blood.2025029836

Source records

europe-pmc · retrieved 2026-09-27T02:08:04.741Z